The 43 rating InvestorsObserver gives to PhaseBio Pharmaceuticals Inc (PHAS) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 33 percent of stocks in the Biotechnology industry, PHAS’s 43 overall rating means the stock scores better than 43 percent of all stocks.
PHAS has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on PHAS!